Zepp Health (NYSE:ZEPP - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Tuesday, Wall Street Zen reports.
Separately, Fundamental Research set a $53.01 price target on Zepp Health and gave the company a "buy" rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $53.01.
View Our Latest Report on ZEPP
Zepp Health Stock Up 0.4%
Zepp Health stock opened at $4.82 on Tuesday. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.90 and a quick ratio of 0.70. The stock has a market capitalization of $70.76 million, a price-to-earnings ratio of -1.75 and a beta of 1.87. Zepp Health has a 1-year low of $3.85 and a 1-year high of $61.85. The business has a fifty day moving average price of $5.08 and a 200-day moving average price of $10.03.
Insider Buying and Selling at Zepp Health
In other news, CFO Cheng Deng sold 9,836 shares of the business's stock in a transaction on Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the sale, the chief financial officer directly owned 114,539 shares of the company's stock, valued at $528,024.79. The trade was a 7.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is owned by company insiders.
Hedge Funds Weigh In On Zepp Health
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio acquired a new position in shares of Zepp Health in the third quarter valued at about $43,000. Osaic Holdings Inc. lifted its holdings in shares of Zepp Health by 239.5% during the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company's stock worth $223,000 after purchasing an additional 5,845 shares during the period. Dimensional Fund Advisors LP acquired a new stake in shares of Zepp Health during the fourth quarter worth about $241,000. Capstone Capital Management Ltd purchased a new stake in Zepp Health in the fourth quarter valued at approximately $298,000. Finally, Mangrove Partners IM LLC purchased a new stake in Zepp Health in the fourth quarter valued at approximately $387,000. Hedge funds and other institutional investors own 52.61% of the company's stock.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health's integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health's offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.